Gait changes in response to subthalamic nucleus stimulation in people with parkinson disease: A case series report

Journal of Neurologic Physical Therapy

Volumn 30, Issue 4, 2006, Pages 184-194

  Kelly, Valerie E ^a   Samii, Ali ^b   Slimp, Jefferson C ^a   Price, Robert ^a   Goodkin, Robert ^a   Shumway Cook, Anne ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Deep brain stimulation; Mobility; Quantitative gait analysis; Timed up and go test; Walking

Indexed keywords

AGED; ARTICLE; BRAIN DEPTH STIMULATION; CASE REPORT; FEMALE; HUMAN; MALE; MIDDLE AGED; NEUROLOGIC DISEASE; PARKINSON DISEASE; PATHOPHYSIOLOGY; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME;

AGED; DEEP BRAIN STIMULATION; FEMALE; GAIT DISORDERS, NEUROLOGIC; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME;

EID: 33947499498     PISSN: 15570576     EISSN: 15570584     Source Type: Journal    
DOI: 10.1097/01.NPT.0000281255.10174.e2     Document Type: Article

References (49)

1. Herzog J, Volkmann J, Krack P, et al. Two-year follow-up of subthalamic deep brain stimulation in Parkinson’s disease. Mov Disord. 2003; 18: 1332-1337.
2. Kleiner-Fisman G, Fisman DN, Sime E, Saint-Cyr JA, Lozano AM, Lang AE. Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease. J Neurosurg. 2003; 99: 489-495.
3. Krack P, Batir A, Van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med. 2003; 349: 1925-1934.
4. Kumar R, Lozano AM, Kim YJ, et al. Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson’s disease. Neurology. 1998; 51: 850-855.
5. Limousin P, Krack P, Pollak P, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med. 1998; 339: 1105-1111.
6. Lopiano L, Rizzone M, Bergamasco B, et al. Deep brain stimulation of the subthalamic nucleus: clinical effectiveness and safety. Neurology. 2001; 56: 552-554.
7. Romito LM, Scerrati M, Contarino MF, Iacoangeli M, Bentivoglio AR, Albanese A. Bilateral high frequency subthalamic stimulation in Parkinson’s disease: long-term neurological follow-up. J Neurosurg Sci. 2003; 47: 119-128.
8. Schupbach WM, Chastan N, Welter ML, et al. Stimulation of the subthalamic nucleus in Parkinson’s disease: a 5 year follow up. J Neurol Neurosurg Psychiatry. 2005; 76: 1640-1644.
9. Tavella A, Bergamasco B, Bosticco E, et al. Deep brain stimulation of the subthalamic nucleus in Parkinson’s disease: long-term follow-up. Neurol Sci. 2002; 23 Suppl 2: S111-112.
10. The DBS for PD Study Group. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson’s disease. N Engl J Med. 2001; 345: 956-963.
11. Piper M, Abrams GM, Marks WJ, Jr. Deep brain stimulation for the treatment of Parkinson’s disease: overview and impact on gait and mobility. Neuro Rehabilitation. 2005; 20: 223-232.
12. Bastian AJ, Kelly VE, Revilla FJ, Perlmutter JS, Mink JW. Different effects of unilateral versus bilateral subthalamic nucleus stimulation on walking and reaching in Parkinson’s disease. Mov Disord. 2003; 18: 1000-1007.
13. Faist M, Xie J, Kurz D, et al. Effect of bilateral subthalamic nucleus stimulation on gait in Parkinson’s disease. Brain. 2001; 124: 1590-1600.
14. Krystkowiak P, Blatt JL, Bourriez JL, et al. Effects of subthalamic nucleus stimulation and levodopa treatment on gait abnormalities in Parkinson disease. Arch Neurol. 2003; 60: 80-84.
15. Stolze H, Klebe S, Poepping M, et al. Effects of bilateral subthalamic nucleus stimulation on parkinsonian gait. Neurology. 2001; 57: 144-146.
16. Xie J, Krack P, Benabid AL, Pollak P. Efect of bilateral subthalamic nucleus stimulation on parkinsonian gait. J Neurol. 2001; 248: 1068-1072.
17. Ferrarin M, Rizzone M, Bergamasco B, et al. Effects of bilateral subthalamic stimulation on gait kinematics and kinetics in Parkinson’s disease. Exp Brain Res. 2005; 160: 517-527.
18. Ashburn A, Stack E, Pickering RM, Ward CD. Predicting fallers in a community-based sample of people with Parkinson’s disease. Gerontology. 2001; 47: 277-281.
19. Karlsen KH, Tandberg E, Arsland D, Larsen J P. Health related quality of life in Parkinson’s disease: a prospective longitudinal study. J Neurol Neurosurg Psychiatry. 2000; 69: 584-589.
20. Wielinski CL, Erickson-Davis C, Wichmann R, Walde-Douglas M, Parashos SA. Falls and injuries resulting from falls among patients with Parkinson’s disease and other parkinsonian syndromes. Mov Disord. 2005; 20: 410-415.
21. Schenkman M, Cutson TM, Zhu CW, Whetten-Goldstein K. A longitudinal evaluation of patients’ perceptions of Parkinson’s disease. Gerontologist. 2002; 42: 790-798.
22. Shumway-Cook A, Goodkin R, Slimp JC, Price R, Samii A. The Effects of unilateral vs. bilateral subthalamic nucleus stimulation on tremor and gait in persons with Parkinson’s disease. Ann Neurol. 2003; 54: S69.
23. Kelly VE, Samii A, Price R, Slimp JC, Goodkin R, Shumway-Cook A. Effects of staged unilateral and bilateral subthalamic nucleus stimulation on gait in people with Parkinson’s disease. J Neurol Phys Ther. 2004; 28: 174.
24. Calne DB, Snow BJ, Lee C. Criteria for diagnosing Parkinson’s disease. Ann Neurol. 1992; 32 Suppl: S125-127.
25. Samii A, Nutt JG, Ransom BR. Parkinson’s disease. Lancet. 2004; 363: 1783-1793.
26. Lozano AM. Surgery for Parkinson’s disease, the five W’s: why, who, what, where, and when. Adv Neurol. 2003; 91: 303-307.
27. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967; 17: 427-442.
28. Fahn S, Elton RL, Members of the UPDRS Development Committee. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent Developments in Parkinson’s Disease. Florham Park, NJ: MacMillan Healthcare Information; 1987: 153-164.
29. Goetz CG, Stebbins GT, Shale HM, et al. Utility of an objective dyskinesia rating scale for Parkinson’s disease: inter-and intrarater reliability assessment. Mov Disord. 1994; 9: 390-394.
30. Langston JW, Widner H, Goetz CG, et al. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord. 1992; 7: 2-13.
31. Lopiano L, Torre E, Benedetti F, et al. Temporal changes in movement time during the switch of the stimulators in Parkinson’s disease patients treated by subthalamic nucleus stimulation. Eur Neurol. 2003; 50: 94-99.
32. Martinez-Martin P, Gil-Nagel A, Gracia LM, Gomez JB, Martinez-Sarries J, Bermejo F. Unified Parkinson’s Disease Rating Scale characteristics and structure. The Cooperative Multicentric Group. Mov Disord. 1994; 9: 76-83.
33. Movement Disorder Society Task Force on Rating Scales for Parkinson’s Disease. The Unified Parkinson’s Disease Rathing Scale (UPDRS): Status and Recommendations. Mov Disord. 2003; 18: 738-750.
34. Schrag A, Sampaio C, Counsell N, Poewe W. Minimal clinically important change on the unified Parkinson’s disease rating scale. Mov Disord. 2006; 21: 1200-1207.
35. Allert N, Volkmann J, Dotse S, Hefter H, Sturm V, Freund HJ. Effects of bilateral pallidal or subthalamic stimulation on gait in advanced Parkinson’s disease. Mov Disord. 2001; 16: 1076-1085.
36. Bakker M, Esselink RA, Munneke M, Limousin-Dowsey P, Speelman HD, Bloem BR. Effects of stereotactic neurosurgery on postural instability and gait in Parkinson’s disease. Mov Disord. 2004; 19: 1092-1099.
37. Bejjani BP, Gervais D, Arnulf I, et al. Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation. J Neurol Neurosurg Psychiatry. 2000; 68: 595-600.
38. Krack P, Pollak P, Limousin P, et al. Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson’s disease. Brain. 1998; 121 (Pt 3): 451-457.
39. Podsiadlo D, Richardson S. The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991; 39: 142-148.
40. Morris S, Morris ME, Iansek R. Reliability of measurements obtained with the Timed “Up & Go” test in people with Parkinson disease. Phys Ther. 2001; 81: 810-818.
41. Stewart RM, Desaloms JM, Sanghera MK. Stimulation of the subthalamic nucleus for the treatment of Parkinson’s disease: postoperative management, programming, and rehabilitation. J Neurosci Nurs. 2005; 37: 108-114.
42. Rodriguez-Oroz MC, Obeso JA, Lang AE, et al. Bilateral deep brain stimulation in Parkinson’s disease: a multicentre study with 4 years follow-up. Brain. 2005; 128: 2240-2249.
43. Russmann H, Ghika J, Villemure JG, et al. Subthalamic nucleus deep brain stimulation in Parkinson disease patients over age 70 years. Neurology. 2004; 63: 1952-1954.
44. Kumar R, Lozano AM, Sime E, Halket E, Lang AE. Comparative Effects of unilateral and bilateral subthalamic nucleus deep brain stimulation. Neurology. 1999; 53: 561-566.
45. Germano IM, Gracies JM, Weisz DJ, Tse W, Koller WC, Olanow CW. Unilateral stimulation of the subthalamic nucleus in Parkinson disease: a double-blind 12-month evaluation study. J Neurosurg. 2004; 101: 36-42.
46. Linazasoro G, Van Blercom N, Lasa A. Unilateral subthalamic deep brain stimulation in advanced Parkinson’s disease. Mov Disord. 2003; 18: 713-716.
47. Rizzone M, Ferrarin M, Pedotti A, et al. High-frequency electrical stimulation of the subthalamic nucleus in Parkinson’s disease: kinetic and kinematic gait analysis. Neurol Sci. 2002; 23 Suppl 2: S103-104.
48. Liu W, McIntire K, Kim SH, et al. Quantitative assessments of the effect of bilateral subthalamic stimulation on multiple aspects of sensorimotor function for patients with Parkinson’s disease. Parkinsonism Relat Disord. 2005; 11: 503-508.
49. Bohannon RW. Comfortable and maximum walking speed of adults aged 20-79 years: reference values and determinants. Age Ageing. 1997; 26: 15-19.